Marstacimab, CAS 1985638-39-8

Product Description: Marstacimab (PF-06741086) is an anti-tissue factor pathway inhibitor (TFPI) monoclonal antibody. Marstacimab can be used for the research of hemophilia[1][2].

Applications: Metabolism-protein/nucleotide metabolism

Formula: N/A

References: [1]Patel-Hett S, et al. Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas. Haemophilia. 2019 Sep;25(5):797-806./[2]Pittman DD, et al. Hemostatic efficacy of marstacimab alone or in combination with bypassing agents in hemophilia plasmas and a mouse bleeding model. Res Pract Thromb Haemost. 2022 Mar 16;6(2):e12679.

CAS Number: 1985638-39-8

Molecular Weight: N/A

Compound Purity: 96.27

Research Area: Metabolic Disease

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99725-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99725-10
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated